Live feed
Filing
SC 13G/A
SC 13G/A0001213900-19-002223·Protalix BioTherapeutics, Inc.
Schedule 13G ownership disclosure
Protalix BioTherapeutics, Inc.
Security class unavailable · CUSIP: 74365A101
Event date: 2018-12-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- Unavailable
- Percent of class
- 6.0000%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001213900-19-002223
- Form type
- SC 13G/A
- Filer
- Protalix BioTherapeutics, Inc.
- CIK
- CIK 1006281
- Filed
- Feb 12, 2019
- Reporting period
- Dec 31, 2018
- Description
- Schedule 13G beneficial ownership